How Long Does Semaglutide Stay in Your Body After a Dose?

Semaglutide's half-life is approximately seven days, so one dose takes around five weeks to fall below detectable levels.
Once-weekly injections are timed to match this profile, keeping circulating levels stable between doses.
After stopping treatment, appetite regulation typically returns gradually over four to eight weeks as levels decline.
The prescriber, not the patient, decides when to adjust, pause or stop semaglutide based on clinical review.

Semaglutide has a half-life of roughly seven days, which means it takes about five weeks for a single dose to clear your system almost entirely. That long-acting profile is precisely why Wegovy is injected just once a week: blood levels stay high enough throughout the week to maintain appetite suppression and slow gastric emptying. Because these are prescription-only medicines, a clinician reviews whether they are appropriate for you before treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the seven-day half-life means in practice — from your first dose to stopping

You've just taken your first Wegovy dose and you're wondering when it actually starts doing something

Most people inject on a Monday evening, pop the used pen in a sharps container, and then wait. A fair question follows: is it doing anything yet? Semaglutide binds to albumin in the bloodstream, and that binding is what gives it the unusually long half-life of around seven days. After a single 0.25 mg starter dose, the medicine reaches its peak concentration roughly one to three days later, then declines slowly. You probably won't feel a dramatic shift from dose one; the starter dose is designed to let your digestive system adjust rather than deliver full therapeutic effect. Real changes in appetite often become more noticeable after several weeks of consistent dosing, once blood levels have built to a steady state across the weekly cycle. If you're curious about the timeline from first injection to meaningful weight change, the Wegovy timeline page covers that in detail. The point here is that semaglutide is never a quick-in, quick-out drug, and if you want to understand exactly how long semaglutide stays in the body at each stage, its chemistry is built for persistence.

The steady-state picture: why weekly dosing keeps semaglutide working between injections

With a seven-day half-life, each dose is still roughly 50 percent present in your body when the next injection is due. That overlap is intentional. After about four to five consecutive weekly doses, semaglutide reaches what pharmacologists call steady state: the amount entering your system each week roughly equals the amount being cleared. At steady state, the appetite-suppressing and gastric-emptying effects are at their most consistent. This is one reason clinical trials measure outcomes at 68 or 72 weeks rather than a few months. The STEP 1 trial, published in the New England Journal of Medicine, followed participants for 68 weeks at the 2.4 mg dose and reported an average body-weight reduction of around 15 percent. That result reflects sustained, elevated drug levels, not a single-dose effect. Practically, steady state also means that missing one dose doesn't immediately undo the medicine's action, but deliberately stopping does start a predictable countdown. If you've noticed your progress slowing after several months, the reasons are usually more complex than drug levels alone; there's a useful breakdown on the Wegovy plateau page.

After you stop: how long Wegovy stays in your body and what changes

This is probably the question you actually came here to answer. If you stop semaglutide injections, the half-life logic runs in reverse: roughly half the remaining concentration clears every seven days. After five half-lives (around five weeks), circulating semaglutide has fallen to less than about three percent of the level present at your last dose. In practice, most of the pharmacological effect has gone by four to six weeks after the final injection. The NHS patient information for semaglutide notes that after stopping, patients should not try to conceive until two months have passed, reflecting this clearance window. For the broader question of how long semaglutide's effects persist in your system after stopping, the dedicated page on that question goes further. Appetite tends to return gradually as levels fall, which is why abrupt stopping without a plan is something prescribers think about carefully. If you're weighing how long you'd stay on treatment altogether, that's a separate clinical question covered on this page about long-term semaglutide use.

A note on the oral form, the 7.2 mg pen, and why the half-life stays the same

The molecule itself doesn't change depending on the delivery format. Whether semaglutide is injected as a 2.4 mg weekly Wegovy dose, taken as the newer 25 mg daily Wegovy tablet, or given at the higher 7.2 mg dose (the single-dose pen approved by the MHRA in April 2026), the half-life of the semaglutide molecule remains approximately seven days. The oral tablet is absorbed differently because it's co-formulated with an absorption enhancer to survive the gut, but once in circulation it behaves the same way. One practical difference: the daily tablet produces a smoother daily peak-and-trough pattern rather than the weekly cycle of an injection, though the underlying pharmacokinetics are comparable. If you're considering your options or thinking about cost alongside clinical factors, the Wegovy price comparison page is worth reading before your consultation. At nume, a real clinician reviews every consultation on the same day it's submitted. Semaglutide is a prescription-only medicine, and the prescriber decides which formulation and dose fits your situation. If you're ready to have that conversation, you can start your free consultation today.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions